Business
WTFnoway.com has created and published a tremendous visualization of US debt. Putting things in understandable context always helps.
On a related note, David Wallechinsky and Noel Brinkerhoff, writing for Government in the Lab, cite Institute for Policy Studies (IPS) researchers: “If corporations and richest Americans were taxed at 1961 rates, US would gain US$716 billion a year.” Tax rates on household incomes greater than US$1 million that are 23.1 percent now were 43.1 percent in 1961. The average corporate tax rate in 1961 was 47.4 percent; it’s 11.1 percent now.
ESRD
The Ventura County Star has published a series of four articles critical of home-town pharmaceutical giant Amgen, the manufacturer and patent holder for Epogen, the drug most commonly used to manage anemia in end-stage renal disease patients on dialysis. Tom Kisken’s “Safety of Epogen dosages questioned” reveals the startling assertion that Amgen has lobbied politically against providing kidney transplant patients with the drugs needed. Kisken’s follow-up with John M. Gonzales from the University of Southern California, “Medicare limits anti-rejection drugs that transplant patients need,” examines the outcomes of the present Medicare benefit for kidney transplant patients (Medicare covers the cost of anti-rejection drugs—which run up to US$2000 monthly—for only 36 months). Kisken then takes a close look at an individual kidney patient who lost a transplanted organ when she could no longer afford her anti-rejection drugs in “Thousand Oaks woman gained miracle kidney, funding restrictions helped take it away.” The final article in the series, Gonzales’s “16 surgeries later, transplant within reach for second-generation dialysis patient,” takes a look at another individual case, a 50-year-old woman waiting for a kidney-pancreas transplant.
The Sunlight Foundation has released Sunlight Health, a smartphone app that provides information on healthcare facilities, including dialysis clinics, and drug information. Sunlight Health is available for both iOS and Android devices.
Politics
James Fallows, writing for the Atlantic, has a fantastic analysis of the difference in policies between Presidents George W. Bush and Barack Obama based on a chart that appeared in the New York Times. Where Bush spent US$5.07 trillion on new policies, Obama has spent US$1.44 trillion. Fallows’s point is that this chart should accompany all discussions of the debt ceiling. Bush’s tax cuts alone were responsible for US$1.8 trillion—more than all of Obama’s new policies including the stimulus and health reform. While governments control policy, they cannot control external shocks.
Markos Moulitsas has written a compelling analysis of “Why the GOP won’t take ‘yes’ for an answer.” According to Kos, the Republicans are intent on embarrassing the president and they desperately need political cover for endorsing and voting for the Ryan budget that drastically cut Medicare.
Publishing
Amazon, Barnes & Noble, and Kobo have all removed stores and links to same from their iOS applications in order to meet Apple’s new rules enforcement for in-app purchases, rather than give Apple a 30 percent cut of their sales. Google Books, on the other hand, was simply disappeared from Apple’s App Store. David Carnoy, writing for CNET, best sums up the situation: “When all is said and done, Apple’s iBooks will be the only iOS app that will allow you to buy e-books directly from within the app. But at least Apple has allowed e-reading apps from other companies to remain in the App Store. You can choose to see that as a magnanimous gesture—or not.” On the magazine side, things are shaking out rather differently. This week Conde Nast announced a partnership with Flipboard. Conde Nast titles Bon Appetit, the New Yorker, and Wired will produce iPad-optimized content for Flipboard, American Express and Lexus will sponsor the Flipboard editions with advertising, and Conde Nast and Flipboard will split the revenue. Tim Carmody, writing for Wired, opines that magazine publishers will prefer to do business with Amazon—even to get on the iPad—routing around Apple altogether.